Company intelligence / Profile preview

Lungpacer Medical

Vancouver/Burnaby, British Columbia, Canadalungpacer.com ↗
Ownership
Private
Employees
~75
Development stage
Commercial
01

Overview

The AeroPace System received FDA premarket approval in December 2024 for improving weaning success in adult patients on mechanical ventilation ≥96 hours who have not weaned. Clinical data show significant reduction in ventilator days and reintubation rates. The investigational AeroNova System has entered a Phase 2 feasibility study targeting acute hypoxemic respiratory failure with the goal of reducing multi-organ ventilator-induced injury.

Therapeutic areas
Pulmonology
Modalities
DeviceNeurostimulation device
Industry
Therapeutic Medical Devices
02

Drug pipeline

2 assets

AeroPace System

Commercial
Indications
Mechanical ventilation weaning

1 more asset in the full pipeline.

Request access →
03

Partnerships

Not explicitly listed—investors include Valiance Life Sciences and NEA

Beyond the preview

Go deeper on Lungpacer Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lungpacer Medical.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call